{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiczkm6nmzmjfkw6qeryryprovvlvstxnppqy6xkum3lexrfqfhiwy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfu55xwzkga2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiafdfhfrsw3pu5q2frfusxm2bsem722hm65omhjcrxffzg5eig2te"
    },
    "mimeType": "image/jpeg",
    "size": 215280
  },
  "path": "/news/2026-02-diseases-ms-cancer.html",
  "publishedAt": "2026-02-27T11:00:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Immunology"
  ],
  "textContent": "A team from the Monash University Biomedicine Discovery Institute has identified a tick-derived evasin that can bind to two major classes of chemokines, a discovery that is important for the development of therapeutics targeting inflammatory and autoimmune diseases. The work is published in the journal Structure.",
  "title": "How a tick could help prevent diseases like MS and cancer"
}